Sartorius Stedim Biotech S.A. (LON: 0RG8)
London
· Delayed Price · Currency is GBP · Price in EUR
224.50
-2.23 (-0.98%)
At close: Jan 31, 2025
Sartorius Stedim Biotech Revenue
Sartorius Stedim Biotech had revenue of 655.40M EUR in the quarter ending September 30, 2024, a decrease of -1.72%. This brings the company's revenue in the last twelve months to 2.74B, down -7.54% year-over-year. In the year 2023, Sartorius Stedim Biotech had annual revenue of 2.78B, down -20.53%.
Revenue (ttm)
2.74B EUR
Revenue Growth
-7.54%
P/S Ratio
n/a
Revenue / Employee
256.57K EUR
Employees
10,662
Market Cap
18.18B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.78B | -717.20M | -20.53% |
Dec 31, 2022 | 3.49B | 605.70M | 20.98% |
Dec 31, 2021 | 2.89B | 976.92M | 51.15% |
Dec 31, 2020 | 1.91B | 469.51M | 32.59% |
Dec 31, 2019 | 1.44B | 228.42M | 18.84% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
Shell | 230.87B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
British American Tobacco p.l.c. | 26.18B |
BP p.l.c. | 144.69B |